Cart
sales@molnova.com
Ibandronate sodium monohydrate
CAS No. 138926-19-9
Ibandronate sodium monohydrate( —— )
Catalog No. M17990 CAS No. 138926-19-9
Ibandronate is a highly potent nitrogen-containing bisphosphonate used for the treatment of osteoporosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 28 | In Stock |
|
| 100MG | 37 | In Stock |
|
| 200MG | 60 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIbandronate sodium monohydrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionIbandronate is a highly potent nitrogen-containing bisphosphonate used for the treatment of osteoporosis.
-
DescriptionIbandronate sodium, also known as Ibandronate sodium monohydrate, is used to treat osteoporosis. It increases bone mineral density, prevents resorption, and decreases osteoclast activity. It may inhibit angiogenesis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number138926-19-9
-
Formula Weight360.23
-
Molecular FormulaC9H23NO7P2·Na·H2O
-
Purity>98% (HPLC)
-
SolubilityH2O : ≥ 100 mg/mL; 278.37 mM
-
SMILESO.[Na].CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O
-
Chemical Namesodium hydrogen (1-hydroxy-3-(methyl(pentyl)amino)-1-phosphonopropyl)phosphonate hydrate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Morgan C, et al. Microvasc Res, 2009, 78(3), 453-458.
molnova catalog
related products
-
α-(difluoromethyl)-D...
α-(difluoromethyl)-DL-Arginine (RMI 71897) is an enzyma-activated, irreversible inhibitor of arginine decarboxylase for E. coli (Ki = 800 μM), Pseudomonas aeruginosa, and Klebsiella pneumoniae.
-
Dacisteine
Dacisteine is an inhibitor of New Delhi metallo-beta-lactamase-1 (NDM-1, IC50 = 1000 μM).
-
Tirzepatide hydrochl...
Tirzepatide hydrochloride (LY3298176 hydrochloride) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist.
